REDUCTION OF THE RISK OF GLAUCOMATOUS OPTIC NEUROPATHY PROGRESSION AFTER COMPLEX NEUROPROTECTION
Open Access
- 1 January 2025
- journal article
- Published by Publishing House Helvetica (Publications)
- No. 2,p. 31-37
Abstract
The problem of glaucomatous neurodegeneration with progressive death of retinal ganglion cells (RGCs) and development of visual field defects can lead to irreversible blindness. In this regard, there is a need to search for effective strategies for neuroprotection of RGCs.Objective. To study the risk of glaucomatous optic neuropathy (GON) progression in patients with primary open-angle glaucoma (POAG) after complex neuroprotection by photobiomodulation (PBM) and nutraceutical formula AREDS2 with ω-3 polyunsaturated fatty acids (PUFA) enhancement and resveratrol for a 12- month follow-up.Material and methods. A total of 137 patients (137 eyes) diagnosed with early or advanced POAG were examined. The main group (group 1) included 74 patients, the control group (group 2) – 63 patients. All patients underwent PBM therapy. Patients of group 1 were additionally recommended the nutraceutical formula AREDS2, enriched with ω-3 PUFA and resveratrol 60 mg (Resvega® Forte; Théa, France; 2 capsules per day) for 12 months. Using Cox regression, the relative risk (cumulative risk function) for predicting the progression of GON was calculated.Results. After 12 months of observation, the median POAG in group 1 exceeded the initial level by 15%. Stabilization and a tendency to improve the parameters of retinal morphometry, Humphrey computer perimetry, as well as an improvement in intraocular blood volume by 24% (p = 0.001) were noted. In the control group, deterioration in all parameters was noted.Conclusions. Complex neuroprotection using PBM and taking the AREDS2 nutraceutical with ω-3 PUFA and resveratrol (60 mg) for 12 months in patients with POAG can reduce the relative risk of progression of GON by 2.27 times (95% DI 1, 38–3.75). Статтю присвячено актуальній проблемі глаукомної нейродегенерації та пошуку ефективних стратегій нейропротекції. Фотобіомодуляція (ФБМ) з антиоксидантною дією ресвератролу є перспективним методом нейропротекції, що дає змогу обґрунтувати його застосування за глаукомної оптичної нейропатії (ГОН) як комплексної нейропротекторної терапії. Використання ФБМ сітківки / диска зорового нерву з 12-місячним прийманням нутрицевтика формули AREDS2, посиленого ω-3 ПНЖК і ресвератролом (60 мг), у хворих на первинну відкритокутову глаукому дає можливість у 2,27 раза знизити відносний ризик прогресування ГОН (95 % DI 1,38–3,75), завдяки покращенню об’ємного внутрішньоочного кровообігу, підвищенню провідності в нервових волокнах зорового нерву з покращенням загальної світлової чутливості зорового аналізатора, та стабілізувати морфометричні показники зорового аналізатора й максимально кориговану гостроту зору.Keywords
This publication has 20 references indexed in Scilit:
- Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma in rodents: A narrative reviewAnimal Models and Experimental Medicine, 2024
- The Relevance of Arterial Blood Pressure in the Management of Glaucoma Progression: A Systematic ReviewAmerican Journal of Hypertension, 2023
- Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic reviewScientific Reports, 2021
- The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic ReviewCellular and Molecular Neurobiology, 2020
- Focal Structure–Function Relationships in Primary Open-Angle Glaucoma Using OCT and OCT-A MeasurementsInvestigative Ophthalmology & Visual Science, 2020
- Correlation of retinal sensitivity in microperimetry with vascular density in optical coherence tomography angiography in primary open-angle glaucomaPLOS ONE, 2020
- Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot TrialPhotobiomodulation, Photomedicine, and Laser Surgery, 2019
- Optic nerve head blood flow regulation during changes in arterial blood pressure in patients with primary open‐angle glaucomaActa Ophthalmologica, 2018
- Mechanisms and Mitochondrial Redox Signaling in PhotobiomodulationPhotochemistry and Photobiology, 2018
- Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotectionEuropean Journal of Pharmacology, 2016